COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    Ultrasonic Comb lice
Previous Study | Return to List | Next Study

Treatment of Head Lice Infestation Using Novel Ultrasonic Comb

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02854878
Recruitment Status : Completed
First Posted : August 4, 2016
Last Update Posted : March 29, 2019
Information provided by (Responsible Party):
ParaSonic Ltd.

Brief Summary:

A pilot study to evaluate safety and efficacy of the Lucy combined with LucyGel in killing head lice and their eggs.

23 participants will be enrolled in this study. The first 12 will be combed with model A and the remaining 11 will be combed with model B

Condition or disease Intervention/treatment Phase
Pediculus Capitis Device: The Lucy ultrasonic comb models A and B combined with the LucyGel Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Actual Study Start Date : November 28, 2016
Actual Primary Completion Date : July 26, 2018
Actual Study Completion Date : July 26, 2018

Arm Intervention/treatment
Experimental: treatment Device: The Lucy ultrasonic comb models A and B combined with the LucyGel

Primary Outcome Measures :
  1. Adverse events of the device and treatment [ Time Frame: up to three days ]
    measured by AE

Secondary Outcome Measures :
  1. Mortality of up to 70% of the mature head lice 3 hours post treatment [ Time Frame: 3 hours post treatment ]
  2. Mortality of up to 50% of the head lice eggs 14 days post treatment. [ Time Frame: 14 days post treatment ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   6 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Males and Females
  • Age 6 years and older at the time of enrollment
  • Must have an active head lice infestation of at least 10live head lice (found within 5 minutes of mechanic search).
  • Hair must be at least 3 cm long.
  • Written informed consent - by patient (if over 18 years of age), or by a parent (if patient is under 18 years of age).
  • For females of childbearing potential, a statement declaring that she is not currently pregnant.

Exclusion Criteria:

  • Used any chemical head lice treatment in the 7 days preceding the trial treatment
  • Used antibiotics in the week preceding treatment
  • Open wounds in the treatment area
  • Skin irritation in the treatment area
  • Individuals with skin/scalp condition at the treatment site which, in the opinion of the investigator, will interfere with treatment or evaluation
  • Known allergies to any of the gel's components
  • Participant that is already enrolled in another study
  • Participant who can't be combed with fine Comb dense ASSY2000

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02854878

Layout table for location information
Herzeliya medical center
Herzliya, Israel
Sponsors and Collaborators
ParaSonic Ltd.
Layout table for additonal information
Responsible Party: ParaSonic Ltd. Identifier: NCT02854878    
Other Study ID Numbers: CL-001
First Posted: August 4, 2016    Key Record Dates
Last Update Posted: March 29, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No